Abstract Library

#1837 Evaluation of Faecal Elastase 1 in Symptomatic Patients with Neuroendocrine Tumours

Introduction: There is limited data on exocrine pancreatic insufficiency in patients on somatostatin analogues(SSA) which affects quality of life in NETs.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Khan M

Authors: Chaudhry R, Newbould R, Williams M, Reid K, Donnelly L,

Keywords: Quality of life, Steatorrhoea, Diarrhea, SST,

#1835 A Prospective Service Evaluation of Systematic Gastroenterological Assessment and Management on Patients with Neuroendocrine Tumours in South East Wales

Introduction: Patients with NETs can experience gastrointestinal(GI) symptoms including diarrhoea, steatorrhoea and urgency.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Donnelly L, Tailor S, Reid K, Williams M, Lewis J,

Keywords: Quality of life, Diarrhea,

#1470 Exploring Gastrointestinal Symptoms And Their Impact on Quality of Life in Patients with Neuroendocrine Tumours

Introduction: Treatments in NETs have been studied for effects on tumour progression and carcinoid syndrome with minimal evidence on gastrointestinal(GI) symptom burden and impact on quality of life(QoL)

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Williams M, Reid K, Ng S, Benny A, Lewis J,

Keywords: Quality of life, symptoms,

#1466 Delays in Diagnosing Neuroendocrine Tumours by Secondary Care Specialities

Introduction: Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) are considered to be a diagnostic challenge, many patients presenting with metastatic disease to a number of specialities in secondary care

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Benny A, Ng S, Reid K, Williams M, Lewis J,

Keywords: Diagnosis, gastroenterology, symptoms,

#686 Hepatic Arterial Embolization for Gastroenteropancreatic NET Liver Metastases

Introduction: Selective hepatic arterial embolization (HAE) with polyvinyl alcohol particles has been shown to be equivalent to chemoembolization for patients with hepatic gastroenteropancreatic (GEP) neuroendocrine metastases. There remains debate about its clinical effectiveness and which patients benefit from treatment.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Wilson C

Authors: Wilson C, Vallance A, Bernstone G, Williams R, Jackson R,

Keywords: hepatic arterial embolisation,